Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens?
Azole resistance in Aspergillus fumigatus is a One Health resistance threat, where azole fungicide exposure compromises the efficacy of medical azoles. The use of the recently authorized fungicide ipflufenoquin, which shares its mode-of-action with a new antifungal olorofim, underscores the need for...
| Autores: | , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2022 |
| País: | España |
| Institución: | Instituto de Salud Carlos III (ISCIII) |
| Repositorio: | Repisalud |
| Idioma: | inglés |
| OAI Identifier: | oai:repisalud.isciii.es:20.500.12105/16006 |
| Acceso en línea: | http://hdl.handle.net/20.500.12105/16006 |
| Access Level: | acceso abierto |
| Palabra clave: | Antifungal Agents Fungicides, Industrial Humans Drug Resistance, Fungal Azoles Aspergillus fumigatus Agriculture Microbial Sensitivity Tests |
| Sumario: | Azole resistance in Aspergillus fumigatus is a One Health resistance threat, where azole fungicide exposure compromises the efficacy of medical azoles. The use of the recently authorized fungicide ipflufenoquin, which shares its mode-of-action with a new antifungal olorofim, underscores the need for risk assessment for dual use of antifungals. |
|---|